Clinical trial · Interventional
Virtual Testis Cancer Lay Support and Survivorship Aim 2
Virtual Testicular Cancer Lay Support and Survivorship (VITALSS Study) Aim 2
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study examines how virtual support can enhance well-being and survivorship in men with testicular cancer. Participants in North Carolina will be randomized into two groups: one with access to a virtual support platform and the other with access to patient educational materials only. After six months, the emotional well-being, self-efficacy, financial toxicity, and quality of life of both groups will be compared at 3 months and 6 months after baseline assessments.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Testicular Cancer | Malignant Testicular Neoplasm | CURATED_EXACT | 0.92 |
| Testis Cancer | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patient educational material | Behavioral | — | UNRESOLVED |
| Virtual support | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Virtual support
- description
- Participants will have access to the virtual support platform.
- interventionNames
- Behavioral: Virtual support
- type
- OTHER
- label
- Patient educational material
- description
- Participants will have access to patient educational material only.
- interventionNames
- Behavioral: Patient educational material
Primary outcomes (1)
- measure
- Emotional well-being scores comparison
- timeFrame
- At baseline, 3-months, and 6-months
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 95 Years
Show eligibility criteria text
Inclusion Criteria: * Men within 5 years of their initial diagnosis of germ cell testicular cancer. * The subject is willing and able to comply with study procedures based on the judgment of the investigator. * Adults aged 18-95 years old. * Electronic informed consent was obtained to participate in the study. Exclusion Criteria: * Woman gender * Non-English speaking * Unwilling or unable to complete informed consent. * On active treatment for another cancer. * Actively receiving chemotherapy, radiation, or surgery for testicular cancer.
References
Publications (0)
Data not yet available